Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1963 3
1964 6
1965 2
1966 6
1967 5
1968 8
1969 11
1970 17
1971 14
1972 13
1973 12
1974 17
1975 14
1976 12
1977 18
1978 15
1979 20
1980 29
1981 33
1982 32
1983 29
1984 26
1985 42
1986 32
1987 26
1988 29
1989 27
1990 18
1991 39
1992 35
1993 46
1994 54
1995 49
1996 56
1997 45
1998 46
1999 55
2000 66
2001 56
2002 55
2003 62
2004 56
2005 89
2006 56
2007 52
2008 53
2009 51
2010 44
2011 39
2012 49
2013 39
2014 50
2015 56
2016 46
2017 39
2018 29
2019 41
2020 32
2021 30
2022 25
2023 30
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

2,011 results

Results by year

Filters applied: . Clear all
Page 1
Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial.
Munro MG, Mainor N, Basu R, Brisinger M, Barreda L. Munro MG, et al. Obstet Gynecol. 2006 Oct;108(4):924-9. doi: 10.1097/01.AOG.0000238343.62063.22. Obstet Gynecol. 2006. PMID: 17012455 Clinical Trial.
OBJECTIVE: To compare the efficacy of multidose medroxyprogesterone acetate and a multidose monophasic combined oral contraceptive (OC) for hemodynamically stable women with nongestational, acute uterine bleeding. ...Emergency surgical procedures were avoided …
OBJECTIVE: To compare the efficacy of multidose medroxyprogesterone acetate and a multidose monophasic combined oral co …
Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
Kaunitz AM. Kaunitz AM. J Reprod Med. 1996 May;41(5 Suppl):419-27. J Reprod Med. 1996. PMID: 8725705 Review.
As the use of depot medroxyprogesterone acetate (DMPA) contraception increases in the United States and worldwide, assessing any impact on the risk of breast and gynecologic cancers becomes increasingly important. ...This article reviews recent epidemiological data …
As the use of depot medroxyprogesterone acetate (DMPA) contraception increases in the United States and worldwide, assessing a …
Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity?
Hermsmeyer RK, Thompson TL, Pohost GM, Kaski JC. Hermsmeyer RK, et al. Nat Clin Pract Cardiovasc Med. 2008 Jul;5(7):387-95. doi: 10.1038/ncpcardio1234. Epub 2008 Jun 3. Nat Clin Pract Cardiovasc Med. 2008. PMID: 18521110 Review.
We are concerned that the apparent blanket condemnation of steroids has not sufficiently distinguished between the cardiovascular actions of estrogen, progesterone and the synthetic progestin medroxyprogesterone acetate. The actions of active metabolites of progesti …
We are concerned that the apparent blanket condemnation of steroids has not sufficiently distinguished between the cardiovascular actions of …
Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.
Westhoff C. Westhoff C. J Reprod Med. 1996 May;41(5 Suppl):401-6. J Reprod Med. 1996. PMID: 8725702 Review.
This review summarizes the existing literature regarding metabolic parameters and mood changes in women using depot medroxyprogesterone acetate (DMPA). MEDLINE and additional bibliographic sources were searched to identify English-language articles describing clinic …
This review summarizes the existing literature regarding metabolic parameters and mood changes in women using depot medroxyprogesterone …
Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice.
Panay N, Nappi RE, Stute P, Palacios S, Paszkowski T, Kagan R, Archer DF, Héroux J, Boolell M. Panay N, et al. Maturitas. 2023 Jun;172:23-31. doi: 10.1016/j.maturitas.2023.04.004. Epub 2023 Apr 13. Maturitas. 2023. PMID: 37084589 Free article.
OBJECTIVES: The Women's Health Initiative study reported an increased risk of venous thromboembolism among menopausal women treated with conjugated equine estrogens/medroxyprogesterone acetate (CEE/MPA) versus placebo. Newer hormone therapies may have a lower venous …
OBJECTIVES: The Women's Health Initiative study reported an increased risk of venous thromboembolism among menopausal women treated with con …
Levonorgestrel-Releasing Intrauterine Systems Versus Oral Cyclic Medroxyprogesterone Acetate in Endometrial Hyperplasia Therapy: A Meta-Analysis.
Yuk JS, Song JY, Lee JH, Park WI, Ahn HS, Kim HJ. Yuk JS, et al. Ann Surg Oncol. 2017 May;24(5):1322-1329. doi: 10.1245/s10434-016-5699-9. Epub 2016 Nov 28. Ann Surg Oncol. 2017. PMID: 27896507 Review.
BACKGROUND: This study aimed to compare the levonorgestrel-releasing intrauterine system (LNG-IUS) with oral cyclic medroxyprogesterone acetate (MPA) in endometrial hyperplasia therapy using randomized controlled trials (RCTs). ...In a subgroup analysis of st …
BACKGROUND: This study aimed to compare the levonorgestrel-releasing intrauterine system (LNG-IUS) with oral cyclic medroxyprogest …
Pharmacokinetics and bioavailability of medroxyprogesterone acetate in the dog and the rat.
Smith D, Enever R, Dey M, Latta D, Weierstall R. Smith D, et al. Biopharm Drug Dispos. 1993 May;14(4):341-55. doi: 10.1002/bdd.2510140407. Biopharm Drug Dispos. 1993. PMID: 8499584
Medroxyprogesterone acetate (MPA) has been administered to rats and dogs. ...Rats received single oral doses of 0.2, 1, 5, and 20 mg kg-1 MPA and multiple oral doses (14 daily doses) of 0.2, 5, and 20 mg kg-1 MPA. ...
Medroxyprogesterone acetate (MPA) has been administered to rats and dogs. ...Rats received single oral doses of 0.2, 1, …
Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density.
Berenson AB, Rahman M, Breitkopf CR, Bi LX. Berenson AB, et al. Obstet Gynecol. 2008 Oct;112(4):788-99. doi: 10.1097/AOG.0b013e3181875b78. Obstet Gynecol. 2008. PMID: 18827121 Free PMC article.
METHODS: Bone mineral density was measured every 6 months for up to 3 years in 703 white, African-American, and Hispanic women using oral contraceptives (OCPs), depot medroxyprogesterone acetate (DMPA), or nonhormonal contraceptives, and in 68 DMPA discontinu …
METHODS: Bone mineral density was measured every 6 months for up to 3 years in 703 white, African-American, and Hispanic women using oral …
Association of partner vasectomy, depot medroxyprogesterone acetate and intrauterine contraceptive devices with ovarian cancer.
Chesang JJ, Richardson AK, Potter JD, Sneyd MJ, Coope P. Chesang JJ, et al. Ann Epidemiol. 2021 Aug;60:15-20. doi: 10.1016/j.annepidem.2021.04.006. Epub 2021 Apr 22. Ann Epidemiol. 2021. PMID: 33895242
PURPOSE: To assess the associations between ovarian cancer and depot medroxyprogesterone acetate (DMPA), intrauterine contraceptive devices (IUDs), and partner vasectomy. ...There were also statistically significant inverse associations between ovarian cancer and us …
PURPOSE: To assess the associations between ovarian cancer and depot medroxyprogesterone acetate (DMPA), intrauterine contrace …
Use of depot medroxyprogesterone acetate and fracture risk.
Meier C, Brauchli YB, Jick SS, Kraenzlin ME, Meier CR. Meier C, et al. J Clin Endocrinol Metab. 2010 Nov;95(11):4909-16. doi: 10.1210/jc.2010-0032. Epub 2010 Aug 4. J Clin Endocrinol Metab. 2010. PMID: 20685865
CONTEXT: Depot medroxyprogesterone acetate (DMPA), which has a high rate of use among teenagers in Europe and the United States, has been associated with impaired bone mineral acquisition during adolescence and accelerated bone loss in later life. ...MAIN OUTCOME ME …
CONTEXT: Depot medroxyprogesterone acetate (DMPA), which has a high rate of use among teenagers in Europe and the United State …
2,011 results